Evaxion Biotech AS (EVAX)

2.100 -0.025 (-1.18%)
Closed USD Disclaimer

Evaxion Biotech AS Company Profile

Equity Type
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
Contact Information
Horsholm,2970 Denmark
45 53 53 18 50
Top Executives
Kirsten Aarup Drejer 66 2021 Member of Advisory Board
Andrew C. Weber 0 0000 Member of Advisory Board
Michael W. Washabaugh 0 0000 Member of Advisory Board
Robert J. Palay 66 0000 Member of Advisory Board
Lars Holtug 64 2021 Independent Director
Soren Brunak 0 0000 Member of Advisory Board
Jürgen Langhärig 0 2019 Head of Business Development & Member of Advisory Board
Marianne Sogaard 54 2020 Chairwoman of the Board
Rajeev Surati 0 0000 Member of Advisory Board
Jeffrey S. Weber 0 0000 Member of Advisory Board
Steven Projan 70 2018 Independent Director
Tom Wylonis 0 0000 Member of Advisory Board
Roberto Prego Pineda 52 2018 Independent Director
Anthony Purcell 0 0000 Member of Advisory Board
Niels Iversen Moeller 43 2008 Co-Founder, VP of Business & Director
Georgina Long 0 0000 Member of Advisory Board
Christian Schilling 0 0000 Member of Advisory Board
Patrick Ott 0 0000 Member of Advisory Board
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.